Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

13 results
Display

Placental Mesenchymal Dysplasia with Fetal Gastroschisis

Kim B, Hyeon J, Lee M, Hwang H, Shin Y, Choi SJ, Kim JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Plasmablastic lymphoma presenting with ileocecal intussusception in an immunocompetent patient

Shin OR, Hyeon J, Kang SB, Kim JO

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Recurred Hydatid Cyst in Pelvic Cavity

Kang J, Chang JB, Bae LS, Kyu HS, Hyeon J, Hyup KS, Lee SE

  • KMID: 2060828
  • Korean J Urol.
  • 1999 Jul;40(7):937-940.
Hydatid disease is Echinococcus granulosus infection in its larva form. It is endemic in many sheep- and cattle-raising countries throughout the world. In Korea seventeen cases have been reported but...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytologic Characteristics of Thymic Adenocarcinoma with Enteric Differentiation: A Study of Four Fine-Needle Aspiration Specimens

Kwon AY, Han J, Cho HY, Kim S, Bang H, Hyeon J

Thymic adenocarcinoma is extremely rare. Although its histologic features have been occasionally reported, a lack of description of the cytologic features has hampered the prompt and accurate diagnosis of this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors

Shin Y, Hyeon J, Lee B, Ha SY, Hong ME, Do IG, Kim KM

BACKGROUND: Counting mitoses is subjective and time-consuming. The adjunctive diagnostic utility of a recently reported mitotic marker, phosphohistone H3 (PHH3), was investigated in gastrointestinal stromal tumors (GISTs). METHODS: We reviewed 77...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy

Ahn S, Hyeon J, Park CK

  • KMID: 2135072
  • Gut Liver.
  • 2013 Mar;7(2):206-212.
BACKGROUND/AIMS: The prognosis after surgical resection of hepatocellular carcinoma (HCC) remains poor because of a high rate of recurrence. Thus, it is crucial to identify patients with a high risk...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-mass-forming Lymphoma of the Left Ventricle Mimicking Non-ischemic Cardiomyopathy on MR Imaging: A Case Report

Shin W, Kim SM, Choe YH, Hyeon J, Kim JS, Chang SA

We report a case of cardiac lymphoma in a 40-year-old man, who had a mediastinal mass which was diagnosed as sclerosing mediastinitis pathologically. The mediastinal mass caused right pulmonary arterial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors

Sim J, Kim H, Hyeon J, Choi YL, Han J

BACKGROUND: Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) are usually effective in lung adenocarcinoma patients with anaplastic lymphoma kinase (ALK) rearrangement. However, even after a good response to ALK-TKI therapy,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma

Hyeon J, Ahn S, Lee JJ, Song DH, Park CK

  • KMID: 2277457
  • Korean J Pathol.
  • 2013 Apr;47(2):130-136.
BACKGROUND: BCL9 enhances beta-catenin-mediated transcriptional activity regardless of the mutational status of the Wnt signaling components and increases the cell proliferation, migration, invasion, and metastatic potential of tumor cells. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection

Hyeon J, Ahn S, Park CK

  • KMID: 1837565
  • Korean J Pathol.
  • 2013 Feb;47(1):9-15.
BACKGROUND: The gene for chromodomain helicase/ATPase DNA binding protein 1-like (CHD1L) was recently identified as a target oncogene within the 1q21 amplicon, which occurs in 46% to 86% of primary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas

Kim SJ, Hyeon J, Cho I, Ko YH, Kim WS

PURPOSE: Pembrolizumab, a programmed cell death protein 1 (PD1) inhibitor inhibits the interplay between PD1 of T-cell and programmed cell death ligand 1 (PDL1) on tumor cells. Although pembrolizumab has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute

Shin Y, Ha SY, Hyeon J, Lee B, Lee J, Jang KT, Kim KM, Park YS, Park CK

PURPOSE: Management of gastroenteropancreatic (GEP) neuroendocrine tumors with liver metastases (NETLM) presents many clinical challenges. Assessment of the extent of disease and primary tumor site is crucial for management. In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
NanoString nCounter® Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry

Hyeon J, Cho SY, Hong ME, Kang SY, Do I, Im YH, Cho EY

PURPOSE: Accurate testing for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) is essential for breast cancer treatment. At present, immunohistochemistry (IHC)/florescence in situ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr